Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Beckman Coulter Life Sciences Features Genomic, Cellular Solutions at SLAS2013

Published: Wednesday, January 09, 2013
Last Updated: Wednesday, January 09, 2013
Bookmark and Share
Workshops, exhibit complemented by Biomek 4000 Workstation grant contest.

Bringing together genomic and cellular sample preparation with integrated solutions to highlight their Automation with a Human Touch theme, Beckman Coulter Life Sciences will offer two workshops and present workstations addressing a range of applications in booth 921 when SLAS2013 convenes in Orlando, Florida, USA, from January 12-16.

Workshops offered by the company begin on Monday, 14 January (2:00-2:45 p.m., Sarasota 1-3), when Lance B. Price, Ph.D., of George Washington University will present “Quantifying the Public Health Burden of Foodborne Extra-intestinal Pathogenic Escherichia coli.”  Dr. Price is director, Center for Food Microbiology and Environmental Health at the Translational Genomics Research Institute.

On Tuesday, 15 January (12:30–1:45 p.m., Osceola 3-4), “Advanced Process and Data Management Software for Automated Systems” will be led by Michael Kowalski, Ph.D., staff applications scientist, Life Science Automation and Genomics and Tim Sherrill, program manager, Integrated Solutions, Life Science Automation, both with Beckman Coulter Life Sciences.

The new Biomek 4000 Liquid Handling Workstation, the latest iteration in the company’s renowned Biomek product line, will be on display in booth 921, where details will be available about a contest for which the prize is a Biomek 4000 Workstation.  The winner, who will receive a workstation configured for the application described in their entry essay, will be announced on 6 April at the American Association for Cancer Research meeting. Information is also available at

Beckman Coulter’s exhibit will feature hands-on applications and software demonstrations performed by a team of scientific experts. Visitors will find setups dedicated to the Biomek 4000 Laboratory Automation Workstation featuring pre-written methods, and the SPRIselect Size Selection Reagent Kit, which speeds and simplifies genomic DNA size selection for next generation sequencing fragment library preparation.  Additionally, innovative workstations and integrated systems for flow cytometry and life science research sample preparation applications will be on display, including new SCARA robotic systems.

“Targeted solutions are at the heart of our automation group’s efforts and directly address the needs of our clients,” said Patrick O’Donnell, Director Americas Marketing, Beckman Coulter Life Sciences.  “We are always excited to be at SLAS, and look forward to once again visiting with scientists and friends.” Visit for more information on Beckman Coulter’s activities at SLAS2013.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Detection Cartridges Expand Applications of Beckman Coulter’s PARADIGM Platform
Beckman Coulter® introduces four detection cartridges for the PARADIGM Detection Platform, its modular plate reader, adding new capabilities for widely used fluorescence and luminescence applications.
Thursday, September 24, 2009
Automation Set to Boost Global Monoclonal Antibody Production
Abcam plc. and Beckman Coulter, Inc. have announced a major bioscience collaboration – to create one of the world’s most sophisticated, automated systems for the production of monoclonal antibodies for use in research.
Monday, December 24, 2007
Beckman Expands Automated Solutions for Biomedical Research
Beckman Chooses Motoman industrial robot arm for integration with the company’s automated liquid handling solutions.
Tuesday, January 24, 2006
Oxford Symposium Spotlights Beckman Coulter's ProteomeLab™ Technology
Beckman Coulter's ProteomeLab PF 2D provides an automated two-dimensional fractionation system.
Wednesday, November 23, 2005
Beckman Coulter Distribution Agreement With CRi

Friday, February 07, 2003
Beckman Coulter and Phenomenex to Co-Market HPLC Products

Tuesday, August 27, 2002
Scientific News
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Potential Target for Treatment of Autism
Grant of $2.4 million will support further research.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos